Kestra Medical Technologies, Ltd.
KMTS
$17.71
-$0.29-1.61%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -142.01% | -6.87% | 0.00% | 9.68% | -3.08% |
| Total Depreciation and Amortization | -2.75% | -11.03% | 0.00% | -39.41% | 4.13% |
| Total Amortization of Deferred Charges | 117.06% | -60.51% | 0.00% | 115.25% | 1.52% |
| Total Other Non-Cash Items | 3,036.55% | -24.12% | 0.00% | -12.95% | 81.58% |
| Change in Net Operating Assets | -2,913.01% | 108.58% | 0.00% | -164.99% | 49.39% |
| Cash from Operations | -28.91% | -3.50% | 0.00% | -18.83% | 5.37% |
| Capital Expenditure | -97.98% | 29.24% | 0.00% | -36.68% | 15.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 1,300.00% |
| Cash from Investing | -91.02% | 29.24% | 0.00% | -38.06% | 16.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | 0.00% | 313.60% | 0.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,807.56% | -101.94% | 0.00% | 2,425.38% | 56.22% |
| Cash from Financing | 180,522.69% | -100.21% | 0.00% | 372.70% | 2.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 912.03% | -165.72% | 0.00% | 599.70% | 22.48% |